Form 4: Hepion Pharmaceuticals Executive Buys Shares

Sentiment:

Insider Transaction (Form 4)


Vincent S Lopriore, Executive Chairman and a Director of Hepion Pharmaceuticals, Inc., purchased 20,000,000 shares of common stock on August 3, 2026 for $0.05 per share.

Summary

  • Open-market purchase: acquired 8,000,000 Common Stock at $0.05 ($400,000) on August 3, 2026; holds 14,250,000 after (Indirect).
  • Open-market purchase: acquired 2,000,000 Common Stock at $0.05 ($100,000) on August 3, 2026; holds 16,250,000 after (Indirect).
  • Open-market purchase: acquired 8,000,000 Warrants on August 3, 2026; holds 8,000,000 after (Indirect).
  • Open-market purchase: acquired 2,000,000 Warrants on August 3, 2026; holds 10,000,000 after (Indirect).

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $500,000, committing personal capital to the stock.

Insider Transactions

Vincent S Lopriore — Director, Officer (Executive Chairman)

DateTransactionSecuritySharesPriceValueHeld After
2026-08-03Open-market purchaseCommon Stock8,000,000$0$400.0K14,250,000
2026-08-03Open-market purchaseCommon Stock2,000,000$0$100.0K16,250,000
2026-08-03Open-market purchaseWarrants8,000,000——8,000,000
2026-08-03Open-market purchaseWarrants2,000,000——10,000,000

Key Dates

DateDescription
2026-08-03Open-market purchase (8,000,000 shares)
2026-08-03Open-market purchase (2,000,000 shares)
2026-08-03Open-market purchase (8,000,000 shares)
2026-08-03Open-market purchase (2,000,000 shares)

Keywords

insider transaction, Form 4, HEPA, Hepion Pharmaceuticals, Inc., bullish, Vincent S Lopriore

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.